Analysis of various malignant neoplasms detected by FDG-PET cancer screening program: Based on a Japanese Nationwide Survey

Annals of Nuclear Medicine

Volumn 25, Issue 1, 2011, Pages 45-54

  Minamimoto, Ryogo ^a   Senda, Michio ^b   Terauchi, Takashi ^c   Jinnouchi, Seishi ^d   Inoue, Tomio ^e   Iinuma, Takeshi ^f   Inoue, Takeshi ^g   Ito, Kengo ^h   Iwata, Hiroshi ⁱ   Uno, Kimiichi ^j   Oku, Shinya ^k   Oguchi, Kazuhiro ^l   Tsukamoto, Eriko ^m   Nakashima, Rumi ⁿ   Nishizawa, Sadahiko ^o   Fukuda, Hiroshi ^p   Murano, Takeshi ^c   Yoshida, Tsuyoshi ^q  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^c NATIONAL CANCER CENTER   (Japan)

^d PET Center   (Japan)

^e YOKOHAMA CITY UNIVERSITY   (Japan)

^f NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^g NATIONAL HOSPITAL ORGANIZATION   (Japan)

^h NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

ⁱ Nagoya PET Imaging Center   (Japan)

^j Nishidai Clinic Diagnostic Imaging Center   (Japan)

^k UNIVERSITY OF AIZU   (Japan)

^l Aizawa Hospital   (Japan)

^m Medical Cooperation Teishinkai Central CI Clinic   (Japan)

ⁿ JAPANESE RED CROSS KUMAMOTO HOSPITAL   (Japan)

^o Hamamatsu Medical Photonics Foundation   (Japan)

^p TOHOKU UNIVERSITY   (Japan)

^q Koga Hospital 21   (Japan)

more..

Author keywords

Cancer screening; Combined examination; Delayed imaging; FDG; PET

Indexed keywords

CA 125 ANTIGEN; FLUORODEOXYGLUCOSE F 18;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER CANCER; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DELAYED DIAGNOSIS; ECHOGRAPHY; ESOPHAGUS CANCER; FALSE POSITIVE RESULT; FEMALE; GALLBLADDER CANCER; GASTROINTESTINAL ENDOSCOPY; HEAD AND NECK CANCER; HEALTH SURVEY; HEPATOBILIARY SYSTEM CANCER; HUMAN; KIDNEY CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MASS SCREENING; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PANCREAS CANCER; PELVIS CANCER; POSITRON EMISSION TOMOGRAPHY; PREDICTIVE VALUE; PRIORITY JOURNAL; QUESTIONNAIRE; STATISTICAL SIGNIFICANCE; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; DATA COLLECTION; EARLY DETECTION OF CANCER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 78751575364     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12149-010-0428-0     Document Type: Article

References (37)

1. HW Yeung H Schöder A Smith M Gonen SM Larson 2005 Clinical value of combined positron emission tomography/computed tomography imaging in the interpretation of 2-deoxy-2-[F-18]fluoro-d-glucose-positron emission tomography studies in cancer patients Mol Imaging Biol 7 229 235 10.1007/s11307-005-4113-y 15912427 (Pubitemid 41348865)
2. M Ide 2006 Cancer screening with FDG-PET Q J Nucl Med Mol Imaging 50 23 27 1:STN:280:DC%2BD287mvVSgtA%3D%3D 16557201
3. R Minamimoto M Senda K Uno S Jinnouchi T Iinuma K Ito, et al. 2007 Performance profile of FDG-PET and PET/CT for cancer screening on the basis of a Japanese Nationwide Survey Ann Nucl Med 21 481 498 10.1007/s12149-007-0061-8 18030580 (Pubitemid 350165651)
4. The guideline of FDG-PET cancer screening. Kaku Igaku. 2004; 41:1-21.
5. The guideline of FDG-PET cancer screening 2007. Kaku Igaku. 2007; 44:1-28.
6. S Kojima B Zhou S Teramukai A Hara N Kosaka Y Matsuo, et al. 2007 Cancer screening of healthy volunteers using whole-body 18F-FDG-PET scans: the Nishidai clinic study Eur J Cancer 43 1842 1848 10.1016/j.ejca.2007.05.010 17614273 (Pubitemid 47238247)
7. S Nishizawa S Kojima S Teramukai M Inubushi H Kodama Y Maeda, et al. 2009 Prospective evaluation of whole-body cancer screening with multiple modalities including [18F]fluorodeoxyglucose positron emission tomography in a healthy population: a preliminary report J Clin Oncol 27 1767 1773 10.1200/JCO.2008.18. 2238 19255324
8. The Foundation of Cancer Research (FPCR). Cancer Statistics in Japan, 2009.
9. H Schöder M Gönen 2007 Screening for cancer with PET and PET/CT: potential and limitations J Nucl Med 48 Suppl 1 4S 18S 17204716
10. H Schöder A Noy M Gönen L Weng D Green YE Erdi, et al. 2005 Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma J Clin Oncol 23 4643 4651 10.1200/JCO.2005.12.072 15837966 (Pubitemid 46224066)
11. BJ Fueger K Yeom J Czernin JW Sayre ME Phelps MS Allen-Auerbach 2009 Comparison of CT, PET, and PET/CT for staging of patients with indolent non- Hodgkin's lymphoma Mol Imaging Biol 11 269 274 10.1007/s11307-009-0200-9 19326177
12. Wahl RL. Principles and practice of PET and PET/CT. 2nd ed. Lippincott Williams & Wilkins; 2009. p. 221-39.
13. P Flamen A Lerut E Van Cutsem W De Wever M Peeters S Stroobants, et al. 2000 Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma J Clin Oncol 18 3202 3210 1:STN:280:DC%2BD3cvotlentw%3D%3D 10986052
14. K Ott WA Weber U Fink H Helmberger K Becker HJ Stein, et al. 2003 Fluorodeoxyglucose-positron emission tomography in adenocarcinomas of the distal esophagus and cardia World J Surg 27 1035 1039 10.1007/s00268-003-7058-9 12917760 (Pubitemid 37186239)
15. G Weber HP Morris 1963 Comparative biochemistry of hepatomas. III. Carbohydrate enzymes in liver tumors of different growth rates Cancer Res 23 987 994 1:CAS:528:DyaF2cXhvVOhtA%3D%3D 14050770
16. M De Santis R Romagnoli A Cristani G Cioni A Casolo FF Vici, et al. 1992 MRI of small hepatocellular carcinoma: comparison with US, CT, DSA, and Lipiodol-CT J Comput Assist Tomogr 16 189 197 10.1097/00004728-199203000-00004 1312096
17. SK Yoon 2008 Recent advances in tumor markers of human hepatocellular carcinoma Intervirology 51 Suppl 1 34 41 1:CAS:528:DC%2BD1cXmvFGns7Y%3D 10.1159/000122596 18544946 (Pubitemid 351821840)
18. P Stefaniuk J Cianciara A Wiercinska-Drapalo 2010 Present and future possibilities for early diagnosis of hepatocellular carcinoma World J Gastroenterol 16 418 424 1:CAS:528:DC%2BC3cXhsV2lurs%3D 10.3748/wjg.v16.i4.418 20101765
19. F Nomura K Ohnishi Y Tanabe 1989 Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels. Analysis of 606 patients Cancer 64 1700 1707 1:STN:280:DyaK3c%2Fgt1Omuw%3D%3D 10.1002/1097-0142(19891015)64:8<1700::AID-CNCR2820640824>3.0.CO;2-Z 2477133
20. F Trevisani PE D'Intino AM Morselli-Labate G Mazzella E Accogli PJ Caraceni, et al. 2001 Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status J Hepatol 34 570 575 1:STN:280:DC%2BD3Mzis1Gisw%3D%3D 10.1016/S0168-8278(00)00053-2 11394657 (Pubitemid 32328514)
21. HG Beger B Rau F Gansauge B Poch KH Link 2003 Treatment of pancreatic cancer: challenge of the facts World J Surg 27 1075 1084 10.1007/s00268-003- 7165-7 12925907 (Pubitemid 37259985)
22. DM Rose D Delbeke RD Beauchamp WC Chapman MP Sandler KW Sharp, et al. 1999 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer Ann Surg 229 729 737 1:STN:280:DyaK1M3kvFKisw%3D%3D 10.1097/00000658-199905000-00016 10235532 discussion (Pubitemid 30187581)
23. D Delbeke DM Rose WC Chapman CW Pinson JK Wright RD Beauchamp, et al. 1999 Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma J Nucl Med 40 1784 1791 1:STN:280: DC%2BD3c%2FivFGjsw%3D%3D 10565771
24. Wahl RL. Principles and practice of PET and PET/CT. 2nd ed. Lippincott Williams & Wilkins; 2009. p. 331-47.
25. WM Steinberg R Gelfand KK Anderson J Glenn SH Kurtzman WF Sindelar, et al. 1986 Comparison of the sensitivity and specificity of the CA19-9 and carcinoembryonic antigen assays in detecting cancer of the pancreas Gastroenterology 90 343 349 1:STN:280:DyaL28%2FotlSiug%3D%3D 2416628
26. T Homma R Tsuchiya 1991 The study of the mass screening of persons without symptoms and of the screening of outpatients with gastrointestinal complaints or icterus for pancreatic cancer in Japan, using CA19-9 and elastase-1 or ultrasonography Int J Pancreatol 9 119 124 1:STN:280: DyaK38%2FnvVKntA%3D%3D 1744437
27. F Montravers D Grahek K Kerrou N Younsi JD Doublet B Gattegno, et al. 2000 Evaluation of FDG uptake by renal malignancies (primary tumor or metastases) using a coincidence detection gamma camera J Nucl Med 41 78 84 1:STN:280:DC%2BD3c7ht1Wgtg%3D%3D 10647608
28. L Kopka U Fischer G Zoeller C Schmidt RH Ringert E Grabbe 1997 Dual-phase helical CT of the kidney: value of the corticomedullary and nephrographic phase for evaluation of renal lesions and preoperative staging of renal cell carcinoma AJR Am J Roentgenol 169 1573 1578 1:STN:280:DyaK1c%2FlsVykug%3D%3D 9393168
29. Wahl RL. Principles and practice of PET and PET/CT. 2nd ed. Lippincott Williams & Wilkins; 2009. p. 348-54.
30. A Chao TC Chang KK Ng S Hsueh HJ Huang HH Chou, et al. 2006 18F-FDG PET in the management of endometrial cancer Eur J Nucl Med Mol Imaging 33 36 44 10.1007/s00259-005-1876-y 16167154 (Pubitemid 41785307)
31. S Nishizawa M Inubushi A Kido M Miyagawa T Inoue K Shinohara, et al. 2008 Incidence and characteristics of uterine leiomyomas with FDG uptake Ann Nucl Med 22 803 810 10.1007/s12149-008-0184-6 19039559
32. K Kitajima K Murakami E Yamasaki Y Kaji K Sugimura 2008 Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI Ann Nucl Med 22 505 512 10.1007/s12149-008-0135-2 18670857
33. H Lerman U Metser D Grisaru A Fishman G Lievshitz E Even-Sapir 2004 Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT J Nucl Med 45 266 271 14960646
34. N Einhorn K Sjövall RC Knapp P Hall RE Scully RC Bast Jr, et al. 1992 Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer Obstet Gynecol 80 14 18 1:STN:280:DyaK383ptlOisQ%3D%3D 1603484
35. S Risum C Høgdall A Loft AK Berthelsen E Høgdall L Nedergaard, et al. 2007 The diagnostic value of PET/CT for primary ovarian cancer-a prospective study Gynecol Oncol 105 145 149 10.1016/j.ygyno.2006.11.022 17229460 (Pubitemid 46454333)
36. RA Hiatt JD Ordoñez 1994 Dipstick urinalysis screening, asymptomatic microhematuria, and subsequent urological cancers in a population-based sample Cancer Epidemiol Biomarkers Prev 3 439 443 1:STN:280:DyaK2M%2Fgtl2qsw%3D%3D 7848421
37. K Kubota M Itoh K Ozaki S Ono M Tashiro K Yamaguchi, et al. 2001 Advantage of delayed whole-body FDG-PET imaging for tumour detection Eur J Nucl Med 28 696 703 1:CAS:528:DC%2BD3MXktlalu74%3D 10.1007/s002590100537 11440029